Medical Care
Global Infectious Diseases In Vitro Diagnostics Market Insights, Forecast to 2030
- Mar 11, 25
- ID: 5067
- Pages: 112
- Figures: 135
- Views: 16
Market Analysis and Insights: Global Infectious Diseases In Vitro Diagnostics Market
The global Infectious Diseases In Vitro Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Infectious Diseases In Vitro Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Infectious Diseases In Vitro Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Infectious Diseases In Vitro Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Infectious Diseases In Vitro Diagnostics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Infectious Diseases In Vitro Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Infectious Diseases In Vitro Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
BD
Abbott
Alere
Quidel
F. Hoffmann-La Roche
Orasure Technologies
Cepheid
Hologic
Qiagen
Bio-Rad Laboratories
Siemens Healthcare
Segment by Type
MRSA
Streptococcus
TB and Drug-resistant TB
Gastro-intestinal Panel Testing
HIV
Hepatitis C
Others
Segment by Application
Immunochemistry
Molecular Diagnostics
Microbiology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Infectious Diseases In Vitro Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infectious Diseases In Vitro Diagnostics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Infectious Diseases In Vitro Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
The global Infectious Diseases In Vitro Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Infectious Diseases In Vitro Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Infectious Diseases In Vitro Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Infectious Diseases In Vitro Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Infectious Diseases In Vitro Diagnostics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Infectious Diseases In Vitro Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Infectious Diseases In Vitro Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
BD
Abbott
Alere
Quidel
F. Hoffmann-La Roche
Orasure Technologies
Cepheid
Hologic
Qiagen
Bio-Rad Laboratories
Siemens Healthcare
Segment by Type
MRSA
Streptococcus
TB and Drug-resistant TB
Gastro-intestinal Panel Testing
HIV
Hepatitis C
Others
Segment by Application
Immunochemistry
Molecular Diagnostics
Microbiology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Infectious Diseases In Vitro Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infectious Diseases In Vitro Diagnostics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Infectious Diseases In Vitro Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 MRSA
1.2.3 Streptococcus
1.2.4 TB and Drug-resistant TB
1.2.5 Gastro-intestinal Panel Testing
1.2.6 HIV
1.2.7 Hepatitis C
1.2.8 Others
1.3 Market by Application
1.3.1 Global Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Immunochemistry
1.3.3 Molecular Diagnostics
1.3.4 Microbiology
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infectious Diseases In Vitro Diagnostics Market Perspective (2019-2030)
2.2 Global Infectious Diseases In Vitro Diagnostics Growth Trends by Region
2.2.1 Infectious Diseases In Vitro Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Infectious Diseases In Vitro Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Infectious Diseases In Vitro Diagnostics Market Dynamics
2.3.1 Infectious Diseases In Vitro Diagnostics Industry Trends
2.3.2 Infectious Diseases In Vitro Diagnostics Market Drivers
2.3.3 Infectious Diseases In Vitro Diagnostics Market Challenges
2.3.4 Infectious Diseases In Vitro Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Infectious Diseases In Vitro Diagnostics by Players
3.1.1 Global Infectious Diseases In Vitro Diagnostics Revenue by Players (2019-2024)
3.1.2 Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Infectious Diseases In Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Infectious Diseases In Vitro Diagnostics, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Infectious Diseases In Vitro Diagnostics Market Concentration Ratio
3.4.1 Global Infectious Diseases In Vitro Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Diseases In Vitro Diagnostics Revenue in 2023
3.5 Global Key Players of Infectious Diseases In Vitro Diagnostics Head office and Area Served
3.6 Global Key Players of Infectious Diseases In Vitro Diagnostics, Product and Application
3.7 Global Key Players of Infectious Diseases In Vitro Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Diseases In Vitro Diagnostics Breakdown Data by Type
4.1 Global Infectious Diseases In Vitro Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Type (2025-2030)
5 Infectious Diseases In Vitro Diagnostics Breakdown Data by Application
5.1 Global Infectious Diseases In Vitro Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Infectious Diseases In Vitro Diagnostics Market Size (2019-2030)
6.2 North America Infectious Diseases In Vitro Diagnostics Market Size by Type
6.2.1 North America Infectious Diseases In Vitro Diagnostics Market Size by Type (2019-2024)
6.2.2 North America Infectious Diseases In Vitro Diagnostics Market Size by Type (2025-2030)
6.2.3 North America Infectious Diseases In Vitro Diagnostics Market Share by Type (2019-2030)
6.3 North America Infectious Diseases In Vitro Diagnostics Market Size by Application
6.3.1 North America Infectious Diseases In Vitro Diagnostics Market Size by Application (2019-2024)
6.3.2 North America Infectious Diseases In Vitro Diagnostics Market Size by Application (2025-2030)
6.3.3 North America Infectious Diseases In Vitro Diagnostics Market Share by Application (2019-2030)
6.4 North America Infectious Diseases In Vitro Diagnostics Market Size by Country
6.4.1 North America Infectious Diseases In Vitro Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Infectious Diseases In Vitro Diagnostics Market Size by Country (2019-2024)
6.4.3 North America Infectious Diseases In Vitro Diagnostics Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Infectious Diseases In Vitro Diagnostics Market Size (2019-2030)
7.2 Europe Infectious Diseases In Vitro Diagnostics Market Size by Type
7.2.1 Europe Infectious Diseases In Vitro Diagnostics Market Size by Type (2019-2024)
7.2.2 Europe Infectious Diseases In Vitro Diagnostics Market Size by Type (2025-2030)
7.2.3 Europe Infectious Diseases In Vitro Diagnostics Market Share by Type (2019-2030)
7.3 Europe Infectious Diseases In Vitro Diagnostics Market Size by Application
7.3.1 Europe Infectious Diseases In Vitro Diagnostics Market Size by Application (2019-2024)
7.3.2 Europe Infectious Diseases In Vitro Diagnostics Market Size by Application (2025-2030)
7.3.3 Europe Infectious Diseases In Vitro Diagnostics Market Share by Application (2019-2030)
7.4 Europe Infectious Diseases In Vitro Diagnostics Market Size by Country
7.4.1 Europe Infectious Diseases In Vitro Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Infectious Diseases In Vitro Diagnostics Market Size by Country (2019-2024)
7.4.3 Europe Infectious Diseases In Vitro Diagnostics Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Infectious Diseases In Vitro Diagnostics Market Size (2019-2030)
8.2 China Infectious Diseases In Vitro Diagnostics Market Size by Type
8.2.1 China Infectious Diseases In Vitro Diagnostics Market Size by Type (2019-2024)
8.2.2 China Infectious Diseases In Vitro Diagnostics Market Size by Type (2025-2030)
8.2.3 China Infectious Diseases In Vitro Diagnostics Market Share by Type (2019-2030)
8.3 China Infectious Diseases In Vitro Diagnostics Market Size by Application
8.3.1 China Infectious Diseases In Vitro Diagnostics Market Size by Application (2019-2024)
8.3.2 China Infectious Diseases In Vitro Diagnostics Market Size by Application (2025-2030)
8.3.3 China Infectious Diseases In Vitro Diagnostics Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Infectious Diseases In Vitro Diagnostics Market Size (2019-2030)
9.2 Asia Infectious Diseases In Vitro Diagnostics Market Size by Type
9.2.1 Asia Infectious Diseases In Vitro Diagnostics Market Size by Type (2019-2024)
9.2.2 Asia Infectious Diseases In Vitro Diagnostics Market Size by Type (2025-2030)
9.2.3 Asia Infectious Diseases In Vitro Diagnostics Market Share by Type (2019-2030)
9.3 Asia Infectious Diseases In Vitro Diagnostics Market Size by Application
9.3.1 Asia Infectious Diseases In Vitro Diagnostics Market Size by Application (2019-2024)
9.3.2 Asia Infectious Diseases In Vitro Diagnostics Market Size by Application (2025-2030)
9.3.3 Asia Infectious Diseases In Vitro Diagnostics Market Share by Application (2019-2030)
9.4 Asia Infectious Diseases In Vitro Diagnostics Market Size by Region
9.4.1 Asia Infectious Diseases In Vitro Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Infectious Diseases In Vitro Diagnostics Market Size by Region (2019-2024)
9.4.3 Asia Infectious Diseases In Vitro Diagnostics Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Details
11.1.2 BD Business Overview
11.1.3 BD Infectious Diseases In Vitro Diagnostics Introduction
11.1.4 BD Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.1.5 BD Recent Developments
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Infectious Diseases In Vitro Diagnostics Introduction
11.2.4 Abbott Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.2.5 Abbott Recent Developments
11.3 Alere
11.3.1 Alere Company Details
11.3.2 Alere Business Overview
11.3.3 Alere Infectious Diseases In Vitro Diagnostics Introduction
11.3.4 Alere Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.3.5 Alere Recent Developments
11.4 Quidel
11.4.1 Quidel Company Details
11.4.2 Quidel Business Overview
11.4.3 Quidel Infectious Diseases In Vitro Diagnostics Introduction
11.4.4 Quidel Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.4.5 Quidel Recent Developments
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.5.5 F. Hoffmann-La Roche Recent Developments
11.6 Orasure Technologies
11.6.1 Orasure Technologies Company Details
11.6.2 Orasure Technologies Business Overview
11.6.3 Orasure Technologies Infectious Diseases In Vitro Diagnostics Introduction
11.6.4 Orasure Technologies Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.6.5 Orasure Technologies Recent Developments
11.7 Cepheid
11.7.1 Cepheid Company Details
11.7.2 Cepheid Business Overview
11.7.3 Cepheid Infectious Diseases In Vitro Diagnostics Introduction
11.7.4 Cepheid Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.7.5 Cepheid Recent Developments
11.8 Hologic
11.8.1 Hologic Company Details
11.8.2 Hologic Business Overview
11.8.3 Hologic Infectious Diseases In Vitro Diagnostics Introduction
11.8.4 Hologic Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.8.5 Hologic Recent Developments
11.9 Qiagen
11.9.1 Qiagen Company Details
11.9.2 Qiagen Business Overview
11.9.3 Qiagen Infectious Diseases In Vitro Diagnostics Introduction
11.9.4 Qiagen Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.9.5 Qiagen Recent Developments
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Details
11.10.2 Bio-Rad Laboratories Business Overview
11.10.3 Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Introduction
11.10.4 Bio-Rad Laboratories Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.10.5 Bio-Rad Laboratories Recent Developments
11.11 Siemens Healthcare
11.11.1 Siemens Healthcare Company Details
11.11.2 Siemens Healthcare Business Overview
11.11.3 Siemens Healthcare Infectious Diseases In Vitro Diagnostics Introduction
11.11.4 Siemens Healthcare Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.11.5 Siemens Healthcare Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 MRSA
1.2.3 Streptococcus
1.2.4 TB and Drug-resistant TB
1.2.5 Gastro-intestinal Panel Testing
1.2.6 HIV
1.2.7 Hepatitis C
1.2.8 Others
1.3 Market by Application
1.3.1 Global Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Immunochemistry
1.3.3 Molecular Diagnostics
1.3.4 Microbiology
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infectious Diseases In Vitro Diagnostics Market Perspective (2019-2030)
2.2 Global Infectious Diseases In Vitro Diagnostics Growth Trends by Region
2.2.1 Infectious Diseases In Vitro Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Infectious Diseases In Vitro Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Infectious Diseases In Vitro Diagnostics Market Dynamics
2.3.1 Infectious Diseases In Vitro Diagnostics Industry Trends
2.3.2 Infectious Diseases In Vitro Diagnostics Market Drivers
2.3.3 Infectious Diseases In Vitro Diagnostics Market Challenges
2.3.4 Infectious Diseases In Vitro Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Infectious Diseases In Vitro Diagnostics by Players
3.1.1 Global Infectious Diseases In Vitro Diagnostics Revenue by Players (2019-2024)
3.1.2 Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Infectious Diseases In Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Infectious Diseases In Vitro Diagnostics, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Infectious Diseases In Vitro Diagnostics Market Concentration Ratio
3.4.1 Global Infectious Diseases In Vitro Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Diseases In Vitro Diagnostics Revenue in 2023
3.5 Global Key Players of Infectious Diseases In Vitro Diagnostics Head office and Area Served
3.6 Global Key Players of Infectious Diseases In Vitro Diagnostics, Product and Application
3.7 Global Key Players of Infectious Diseases In Vitro Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Diseases In Vitro Diagnostics Breakdown Data by Type
4.1 Global Infectious Diseases In Vitro Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Type (2025-2030)
5 Infectious Diseases In Vitro Diagnostics Breakdown Data by Application
5.1 Global Infectious Diseases In Vitro Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Infectious Diseases In Vitro Diagnostics Market Size (2019-2030)
6.2 North America Infectious Diseases In Vitro Diagnostics Market Size by Type
6.2.1 North America Infectious Diseases In Vitro Diagnostics Market Size by Type (2019-2024)
6.2.2 North America Infectious Diseases In Vitro Diagnostics Market Size by Type (2025-2030)
6.2.3 North America Infectious Diseases In Vitro Diagnostics Market Share by Type (2019-2030)
6.3 North America Infectious Diseases In Vitro Diagnostics Market Size by Application
6.3.1 North America Infectious Diseases In Vitro Diagnostics Market Size by Application (2019-2024)
6.3.2 North America Infectious Diseases In Vitro Diagnostics Market Size by Application (2025-2030)
6.3.3 North America Infectious Diseases In Vitro Diagnostics Market Share by Application (2019-2030)
6.4 North America Infectious Diseases In Vitro Diagnostics Market Size by Country
6.4.1 North America Infectious Diseases In Vitro Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Infectious Diseases In Vitro Diagnostics Market Size by Country (2019-2024)
6.4.3 North America Infectious Diseases In Vitro Diagnostics Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Infectious Diseases In Vitro Diagnostics Market Size (2019-2030)
7.2 Europe Infectious Diseases In Vitro Diagnostics Market Size by Type
7.2.1 Europe Infectious Diseases In Vitro Diagnostics Market Size by Type (2019-2024)
7.2.2 Europe Infectious Diseases In Vitro Diagnostics Market Size by Type (2025-2030)
7.2.3 Europe Infectious Diseases In Vitro Diagnostics Market Share by Type (2019-2030)
7.3 Europe Infectious Diseases In Vitro Diagnostics Market Size by Application
7.3.1 Europe Infectious Diseases In Vitro Diagnostics Market Size by Application (2019-2024)
7.3.2 Europe Infectious Diseases In Vitro Diagnostics Market Size by Application (2025-2030)
7.3.3 Europe Infectious Diseases In Vitro Diagnostics Market Share by Application (2019-2030)
7.4 Europe Infectious Diseases In Vitro Diagnostics Market Size by Country
7.4.1 Europe Infectious Diseases In Vitro Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Infectious Diseases In Vitro Diagnostics Market Size by Country (2019-2024)
7.4.3 Europe Infectious Diseases In Vitro Diagnostics Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Infectious Diseases In Vitro Diagnostics Market Size (2019-2030)
8.2 China Infectious Diseases In Vitro Diagnostics Market Size by Type
8.2.1 China Infectious Diseases In Vitro Diagnostics Market Size by Type (2019-2024)
8.2.2 China Infectious Diseases In Vitro Diagnostics Market Size by Type (2025-2030)
8.2.3 China Infectious Diseases In Vitro Diagnostics Market Share by Type (2019-2030)
8.3 China Infectious Diseases In Vitro Diagnostics Market Size by Application
8.3.1 China Infectious Diseases In Vitro Diagnostics Market Size by Application (2019-2024)
8.3.2 China Infectious Diseases In Vitro Diagnostics Market Size by Application (2025-2030)
8.3.3 China Infectious Diseases In Vitro Diagnostics Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Infectious Diseases In Vitro Diagnostics Market Size (2019-2030)
9.2 Asia Infectious Diseases In Vitro Diagnostics Market Size by Type
9.2.1 Asia Infectious Diseases In Vitro Diagnostics Market Size by Type (2019-2024)
9.2.2 Asia Infectious Diseases In Vitro Diagnostics Market Size by Type (2025-2030)
9.2.3 Asia Infectious Diseases In Vitro Diagnostics Market Share by Type (2019-2030)
9.3 Asia Infectious Diseases In Vitro Diagnostics Market Size by Application
9.3.1 Asia Infectious Diseases In Vitro Diagnostics Market Size by Application (2019-2024)
9.3.2 Asia Infectious Diseases In Vitro Diagnostics Market Size by Application (2025-2030)
9.3.3 Asia Infectious Diseases In Vitro Diagnostics Market Share by Application (2019-2030)
9.4 Asia Infectious Diseases In Vitro Diagnostics Market Size by Region
9.4.1 Asia Infectious Diseases In Vitro Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Infectious Diseases In Vitro Diagnostics Market Size by Region (2019-2024)
9.4.3 Asia Infectious Diseases In Vitro Diagnostics Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Details
11.1.2 BD Business Overview
11.1.3 BD Infectious Diseases In Vitro Diagnostics Introduction
11.1.4 BD Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.1.5 BD Recent Developments
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Infectious Diseases In Vitro Diagnostics Introduction
11.2.4 Abbott Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.2.5 Abbott Recent Developments
11.3 Alere
11.3.1 Alere Company Details
11.3.2 Alere Business Overview
11.3.3 Alere Infectious Diseases In Vitro Diagnostics Introduction
11.3.4 Alere Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.3.5 Alere Recent Developments
11.4 Quidel
11.4.1 Quidel Company Details
11.4.2 Quidel Business Overview
11.4.3 Quidel Infectious Diseases In Vitro Diagnostics Introduction
11.4.4 Quidel Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.4.5 Quidel Recent Developments
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.5.5 F. Hoffmann-La Roche Recent Developments
11.6 Orasure Technologies
11.6.1 Orasure Technologies Company Details
11.6.2 Orasure Technologies Business Overview
11.6.3 Orasure Technologies Infectious Diseases In Vitro Diagnostics Introduction
11.6.4 Orasure Technologies Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.6.5 Orasure Technologies Recent Developments
11.7 Cepheid
11.7.1 Cepheid Company Details
11.7.2 Cepheid Business Overview
11.7.3 Cepheid Infectious Diseases In Vitro Diagnostics Introduction
11.7.4 Cepheid Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.7.5 Cepheid Recent Developments
11.8 Hologic
11.8.1 Hologic Company Details
11.8.2 Hologic Business Overview
11.8.3 Hologic Infectious Diseases In Vitro Diagnostics Introduction
11.8.4 Hologic Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.8.5 Hologic Recent Developments
11.9 Qiagen
11.9.1 Qiagen Company Details
11.9.2 Qiagen Business Overview
11.9.3 Qiagen Infectious Diseases In Vitro Diagnostics Introduction
11.9.4 Qiagen Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.9.5 Qiagen Recent Developments
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Details
11.10.2 Bio-Rad Laboratories Business Overview
11.10.3 Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Introduction
11.10.4 Bio-Rad Laboratories Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.10.5 Bio-Rad Laboratories Recent Developments
11.11 Siemens Healthcare
11.11.1 Siemens Healthcare Company Details
11.11.2 Siemens Healthcare Business Overview
11.11.3 Siemens Healthcare Infectious Diseases In Vitro Diagnostics Introduction
11.11.4 Siemens Healthcare Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
11.11.5 Siemens Healthcare Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of MRSA
Table 3. Key Players of Streptococcus
Table 4. Key Players of TB and Drug-resistant TB
Table 5. Key Players of Gastro-intestinal Panel Testing
Table 6. Key Players of HIV
Table 7. Key Players of Hepatitis C
Table 8. Key Players of Others
Table 9. Global Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 10. Global Infectious Diseases In Vitro Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Infectious Diseases In Vitro Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global Infectious Diseases In Vitro Diagnostics Market Share by Region (2019-2024)
Table 13. Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global Infectious Diseases In Vitro Diagnostics Market Share by Region (2025-2030)
Table 15. Infectious Diseases In Vitro Diagnostics Market Trends
Table 16. Infectious Diseases In Vitro Diagnostics Market Drivers
Table 17. Infectious Diseases In Vitro Diagnostics Market Challenges
Table 18. Infectious Diseases In Vitro Diagnostics Market Restraints
Table 19. Global Infectious Diseases In Vitro Diagnostics Revenue by Players (2019-2024) & (US$ Million)
Table 20. Global Infectious Diseases In Vitro Diagnostics Revenue Share by Players (2019-2024)
Table 21. Global Top Infectious Diseases In Vitro Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Diseases In Vitro Diagnostics as of 2023)
Table 22. Global Infectious Diseases In Vitro Diagnostics Industry Ranking 2022 VS 2023 VS 2024
Table 23. Global 5 Largest Players Market Share by Infectious Diseases In Vitro Diagnostics Revenue (CR5 and HHI) & (2019-2024)
Table 24. Global Key Players of Infectious Diseases In Vitro Diagnostics, Headquarters and Area Served
Table 25. Global Key Players of Infectious Diseases In Vitro Diagnostics, Product and Application
Table 26. Global Key Players of Infectious Diseases In Vitro Diagnostics, Product and Application
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Infectious Diseases In Vitro Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Type (2019-2024)
Table 30. Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Type (2025-2030)
Table 32. Global Infectious Diseases In Vitro Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global Infectious Diseases In Vitro Diagnostics Revenue Share by Application (2019-2024)
Table 34. Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global Infectious Diseases In Vitro Diagnostics Revenue Share by Application (2025-2030)
Table 36. North America Infectious Diseases In Vitro Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 37. North America Infectious Diseases In Vitro Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 38. North America Infectious Diseases In Vitro Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 39. North America Infectious Diseases In Vitro Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 40. North America Infectious Diseases In Vitro Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. North America Infectious Diseases In Vitro Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 42. North America Infectious Diseases In Vitro Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 43. Europe Infectious Diseases In Vitro Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 44. Europe Infectious Diseases In Vitro Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 45. Europe Infectious Diseases In Vitro Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 46. Europe Infectious Diseases In Vitro Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 47. Europe Infectious Diseases In Vitro Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Europe Infectious Diseases In Vitro Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 49. Europe Infectious Diseases In Vitro Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 50. China Infectious Diseases In Vitro Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 51. China Infectious Diseases In Vitro Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 52. China Infectious Diseases In Vitro Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 53. China Infectious Diseases In Vitro Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 54. Asia Infectious Diseases In Vitro Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 55. Asia Infectious Diseases In Vitro Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 56. Asia Infectious Diseases In Vitro Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 57. Asia Infectious Diseases In Vitro Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 58. Asia Infectious Diseases In Vitro Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 59. Asia Infectious Diseases In Vitro Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 60. Asia Infectious Diseases In Vitro Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 66. Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 67. Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 68. BD Company Details
Table 69. BD Business Overview
Table 70. BD Infectious Diseases In Vitro Diagnostics Product
Table 71. BD Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 72. BD Recent Developments
Table 73. Abbott Company Details
Table 74. Abbott Business Overview
Table 75. Abbott Infectious Diseases In Vitro Diagnostics Product
Table 76. Abbott Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 77. Abbott Recent Developments
Table 78. Alere Company Details
Table 79. Alere Business Overview
Table 80. Alere Infectious Diseases In Vitro Diagnostics Product
Table 81. Alere Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 82. Alere Recent Developments
Table 83. Quidel Company Details
Table 84. Quidel Business Overview
Table 85. Quidel Infectious Diseases In Vitro Diagnostics Product
Table 86. Quidel Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 87. Quidel Recent Developments
Table 88. F. Hoffmann-La Roche Company Details
Table 89. F. Hoffmann-La Roche Business Overview
Table 90. F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Product
Table 91. F. Hoffmann-La Roche Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 92. F. Hoffmann-La Roche Recent Developments
Table 93. Orasure Technologies Company Details
Table 94. Orasure Technologies Business Overview
Table 95. Orasure Technologies Infectious Diseases In Vitro Diagnostics Product
Table 96. Orasure Technologies Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 97. Orasure Technologies Recent Developments
Table 98. Cepheid Company Details
Table 99. Cepheid Business Overview
Table 100. Cepheid Infectious Diseases In Vitro Diagnostics Product
Table 101. Cepheid Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 102. Cepheid Recent Developments
Table 103. Hologic Company Details
Table 104. Hologic Business Overview
Table 105. Hologic Infectious Diseases In Vitro Diagnostics Product
Table 106. Hologic Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 107. Hologic Recent Developments
Table 108. Qiagen Company Details
Table 109. Qiagen Business Overview
Table 110. Qiagen Infectious Diseases In Vitro Diagnostics Product
Table 111. Qiagen Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 112. Qiagen Recent Developments
Table 113. Bio-Rad Laboratories Company Details
Table 114. Bio-Rad Laboratories Business Overview
Table 115. Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Product
Table 116. Bio-Rad Laboratories Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 117. Bio-Rad Laboratories Recent Developments
Table 118. Siemens Healthcare Company Details
Table 119. Siemens Healthcare Business Overview
Table 120. Siemens Healthcare Infectious Diseases In Vitro Diagnostics Product
Table 121. Siemens Healthcare Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 122. Siemens Healthcare Recent Developments
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Infectious Diseases In Vitro Diagnostics Market Share by Type: 2023 VS 2030
Figure 3. MRSA Features
Figure 4. Streptococcus Features
Figure 5. TB and Drug-resistant TB Features
Figure 6. Gastro-intestinal Panel Testing Features
Figure 7. HIV Features
Figure 8. Hepatitis C Features
Figure 9. Others Features
Figure 10. Global Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 11. Global Infectious Diseases In Vitro Diagnostics Market Share by Application: 2023 VS 2030
Figure 12. Immunochemistry Case Studies
Figure 13. Molecular Diagnostics Case Studies
Figure 14. Microbiology Case Studies
Figure 15. Others Case Studies
Figure 16. Infectious Diseases In Vitro Diagnostics Report Years Considered
Figure 17. Global Infectious Diseases In Vitro Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global Infectious Diseases In Vitro Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Infectious Diseases In Vitro Diagnostics Market Share by Region: 2023 VS 2030
Figure 20. Global Infectious Diseases In Vitro Diagnostics Market Share by Players in 2023
Figure 21. Global Top Infectious Diseases In Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Diseases In Vitro Diagnostics as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Infectious Diseases In Vitro Diagnostics Revenue in 2023
Figure 23. North America Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Infectious Diseases In Vitro Diagnostics Market Share by Type (2019-2030)
Figure 25. North America Infectious Diseases In Vitro Diagnostics Market Share by Application (2019-2030)
Figure 26. North America Infectious Diseases In Vitro Diagnostics Market Share by Country (2019-2030)
Figure 27. United States Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Canada Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Europe Infectious Diseases In Vitro Diagnostics Market Size YoY (2019-2030) & (US$ Million)
Figure 30. Europe Infectious Diseases In Vitro Diagnostics Market Share by Type (2019-2030)
Figure 31. Europe Infectious Diseases In Vitro Diagnostics Market Share by Application (2019-2030)
Figure 32. Europe Infectious Diseases In Vitro Diagnostics Market Share by Country (2019-2030)
Figure 33. Germany Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. France Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. U.K. Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Italy Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Russia Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Nordic Countries Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. China Infectious Diseases In Vitro Diagnostics Market Size YoY (2019-2030) & (US$ Million)
Figure 40. China Infectious Diseases In Vitro Diagnostics Market Share by Type (2019-2030)
Figure 41. China Infectious Diseases In Vitro Diagnostics Market Share by Application (2019-2030)
Figure 42. Asia Infectious Diseases In Vitro Diagnostics Market Size YoY (2019-2030) & (US$ Million)
Figure 43. Asia Infectious Diseases In Vitro Diagnostics Market Share by Type (2019-2030)
Figure 44. Asia Infectious Diseases In Vitro Diagnostics Market Share by Application (2019-2030)
Figure 45. Asia Infectious Diseases In Vitro Diagnostics Market Share by Region (2019-2030)
Figure 46. Japan Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. South Korea Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. China Taiwan Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Southeast Asia Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. India Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Australia Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size YoY (2019-2030) & (US$ Million)
Figure 53. Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Share by Type (2019-2030)
Figure 54. Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Share by Application (2019-2030)
Figure 55. Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Share by Country (2019-2030)
Figure 56. Brazil Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Mexico Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. Turkey Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 59. Saudi Arabia Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 60. Israel Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 61. GCC Countries Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 62. BD Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
Figure 63. Abbott Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
Figure 64. Alere Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
Figure 65. Quidel Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
Figure 66. F. Hoffmann-La Roche Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
Figure 67. Orasure Technologies Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
Figure 68. Cepheid Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
Figure 69. Hologic Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
Figure 70. Qiagen Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
Figure 71. Bio-Rad Laboratories Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
Figure 72. Siemens Healthcare Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
Table 1. Global Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of MRSA
Table 3. Key Players of Streptococcus
Table 4. Key Players of TB and Drug-resistant TB
Table 5. Key Players of Gastro-intestinal Panel Testing
Table 6. Key Players of HIV
Table 7. Key Players of Hepatitis C
Table 8. Key Players of Others
Table 9. Global Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 10. Global Infectious Diseases In Vitro Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Infectious Diseases In Vitro Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global Infectious Diseases In Vitro Diagnostics Market Share by Region (2019-2024)
Table 13. Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global Infectious Diseases In Vitro Diagnostics Market Share by Region (2025-2030)
Table 15. Infectious Diseases In Vitro Diagnostics Market Trends
Table 16. Infectious Diseases In Vitro Diagnostics Market Drivers
Table 17. Infectious Diseases In Vitro Diagnostics Market Challenges
Table 18. Infectious Diseases In Vitro Diagnostics Market Restraints
Table 19. Global Infectious Diseases In Vitro Diagnostics Revenue by Players (2019-2024) & (US$ Million)
Table 20. Global Infectious Diseases In Vitro Diagnostics Revenue Share by Players (2019-2024)
Table 21. Global Top Infectious Diseases In Vitro Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Diseases In Vitro Diagnostics as of 2023)
Table 22. Global Infectious Diseases In Vitro Diagnostics Industry Ranking 2022 VS 2023 VS 2024
Table 23. Global 5 Largest Players Market Share by Infectious Diseases In Vitro Diagnostics Revenue (CR5 and HHI) & (2019-2024)
Table 24. Global Key Players of Infectious Diseases In Vitro Diagnostics, Headquarters and Area Served
Table 25. Global Key Players of Infectious Diseases In Vitro Diagnostics, Product and Application
Table 26. Global Key Players of Infectious Diseases In Vitro Diagnostics, Product and Application
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Infectious Diseases In Vitro Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Type (2019-2024)
Table 30. Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Type (2025-2030)
Table 32. Global Infectious Diseases In Vitro Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global Infectious Diseases In Vitro Diagnostics Revenue Share by Application (2019-2024)
Table 34. Global Infectious Diseases In Vitro Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global Infectious Diseases In Vitro Diagnostics Revenue Share by Application (2025-2030)
Table 36. North America Infectious Diseases In Vitro Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 37. North America Infectious Diseases In Vitro Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 38. North America Infectious Diseases In Vitro Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 39. North America Infectious Diseases In Vitro Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 40. North America Infectious Diseases In Vitro Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. North America Infectious Diseases In Vitro Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 42. North America Infectious Diseases In Vitro Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 43. Europe Infectious Diseases In Vitro Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 44. Europe Infectious Diseases In Vitro Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 45. Europe Infectious Diseases In Vitro Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 46. Europe Infectious Diseases In Vitro Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 47. Europe Infectious Diseases In Vitro Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Europe Infectious Diseases In Vitro Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 49. Europe Infectious Diseases In Vitro Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 50. China Infectious Diseases In Vitro Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 51. China Infectious Diseases In Vitro Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 52. China Infectious Diseases In Vitro Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 53. China Infectious Diseases In Vitro Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 54. Asia Infectious Diseases In Vitro Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 55. Asia Infectious Diseases In Vitro Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 56. Asia Infectious Diseases In Vitro Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 57. Asia Infectious Diseases In Vitro Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 58. Asia Infectious Diseases In Vitro Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 59. Asia Infectious Diseases In Vitro Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 60. Asia Infectious Diseases In Vitro Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Type (2025-2030) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Application (2025-2030) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 66. Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 67. Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 68. BD Company Details
Table 69. BD Business Overview
Table 70. BD Infectious Diseases In Vitro Diagnostics Product
Table 71. BD Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 72. BD Recent Developments
Table 73. Abbott Company Details
Table 74. Abbott Business Overview
Table 75. Abbott Infectious Diseases In Vitro Diagnostics Product
Table 76. Abbott Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 77. Abbott Recent Developments
Table 78. Alere Company Details
Table 79. Alere Business Overview
Table 80. Alere Infectious Diseases In Vitro Diagnostics Product
Table 81. Alere Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 82. Alere Recent Developments
Table 83. Quidel Company Details
Table 84. Quidel Business Overview
Table 85. Quidel Infectious Diseases In Vitro Diagnostics Product
Table 86. Quidel Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 87. Quidel Recent Developments
Table 88. F. Hoffmann-La Roche Company Details
Table 89. F. Hoffmann-La Roche Business Overview
Table 90. F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Product
Table 91. F. Hoffmann-La Roche Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 92. F. Hoffmann-La Roche Recent Developments
Table 93. Orasure Technologies Company Details
Table 94. Orasure Technologies Business Overview
Table 95. Orasure Technologies Infectious Diseases In Vitro Diagnostics Product
Table 96. Orasure Technologies Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 97. Orasure Technologies Recent Developments
Table 98. Cepheid Company Details
Table 99. Cepheid Business Overview
Table 100. Cepheid Infectious Diseases In Vitro Diagnostics Product
Table 101. Cepheid Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 102. Cepheid Recent Developments
Table 103. Hologic Company Details
Table 104. Hologic Business Overview
Table 105. Hologic Infectious Diseases In Vitro Diagnostics Product
Table 106. Hologic Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 107. Hologic Recent Developments
Table 108. Qiagen Company Details
Table 109. Qiagen Business Overview
Table 110. Qiagen Infectious Diseases In Vitro Diagnostics Product
Table 111. Qiagen Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 112. Qiagen Recent Developments
Table 113. Bio-Rad Laboratories Company Details
Table 114. Bio-Rad Laboratories Business Overview
Table 115. Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Product
Table 116. Bio-Rad Laboratories Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 117. Bio-Rad Laboratories Recent Developments
Table 118. Siemens Healthcare Company Details
Table 119. Siemens Healthcare Business Overview
Table 120. Siemens Healthcare Infectious Diseases In Vitro Diagnostics Product
Table 121. Siemens Healthcare Revenue in Infectious Diseases In Vitro Diagnostics Business (2019-2024) & (US$ Million)
Table 122. Siemens Healthcare Recent Developments
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Infectious Diseases In Vitro Diagnostics Market Share by Type: 2023 VS 2030
Figure 3. MRSA Features
Figure 4. Streptococcus Features
Figure 5. TB and Drug-resistant TB Features
Figure 6. Gastro-intestinal Panel Testing Features
Figure 7. HIV Features
Figure 8. Hepatitis C Features
Figure 9. Others Features
Figure 10. Global Infectious Diseases In Vitro Diagnostics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 11. Global Infectious Diseases In Vitro Diagnostics Market Share by Application: 2023 VS 2030
Figure 12. Immunochemistry Case Studies
Figure 13. Molecular Diagnostics Case Studies
Figure 14. Microbiology Case Studies
Figure 15. Others Case Studies
Figure 16. Infectious Diseases In Vitro Diagnostics Report Years Considered
Figure 17. Global Infectious Diseases In Vitro Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global Infectious Diseases In Vitro Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Infectious Diseases In Vitro Diagnostics Market Share by Region: 2023 VS 2030
Figure 20. Global Infectious Diseases In Vitro Diagnostics Market Share by Players in 2023
Figure 21. Global Top Infectious Diseases In Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Diseases In Vitro Diagnostics as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Infectious Diseases In Vitro Diagnostics Revenue in 2023
Figure 23. North America Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Infectious Diseases In Vitro Diagnostics Market Share by Type (2019-2030)
Figure 25. North America Infectious Diseases In Vitro Diagnostics Market Share by Application (2019-2030)
Figure 26. North America Infectious Diseases In Vitro Diagnostics Market Share by Country (2019-2030)
Figure 27. United States Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Canada Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Europe Infectious Diseases In Vitro Diagnostics Market Size YoY (2019-2030) & (US$ Million)
Figure 30. Europe Infectious Diseases In Vitro Diagnostics Market Share by Type (2019-2030)
Figure 31. Europe Infectious Diseases In Vitro Diagnostics Market Share by Application (2019-2030)
Figure 32. Europe Infectious Diseases In Vitro Diagnostics Market Share by Country (2019-2030)
Figure 33. Germany Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. France Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. U.K. Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Italy Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Russia Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Nordic Countries Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. China Infectious Diseases In Vitro Diagnostics Market Size YoY (2019-2030) & (US$ Million)
Figure 40. China Infectious Diseases In Vitro Diagnostics Market Share by Type (2019-2030)
Figure 41. China Infectious Diseases In Vitro Diagnostics Market Share by Application (2019-2030)
Figure 42. Asia Infectious Diseases In Vitro Diagnostics Market Size YoY (2019-2030) & (US$ Million)
Figure 43. Asia Infectious Diseases In Vitro Diagnostics Market Share by Type (2019-2030)
Figure 44. Asia Infectious Diseases In Vitro Diagnostics Market Share by Application (2019-2030)
Figure 45. Asia Infectious Diseases In Vitro Diagnostics Market Share by Region (2019-2030)
Figure 46. Japan Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. South Korea Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. China Taiwan Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Southeast Asia Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. India Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Australia Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Size YoY (2019-2030) & (US$ Million)
Figure 53. Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Share by Type (2019-2030)
Figure 54. Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Share by Application (2019-2030)
Figure 55. Middle East, Africa, and Latin America Infectious Diseases In Vitro Diagnostics Market Share by Country (2019-2030)
Figure 56. Brazil Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Mexico Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. Turkey Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 59. Saudi Arabia Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 60. Israel Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 61. GCC Countries Infectious Diseases In Vitro Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 62. BD Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
Figure 63. Abbott Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
Figure 64. Alere Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
Figure 65. Quidel Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
Figure 66. F. Hoffmann-La Roche Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
Figure 67. Orasure Technologies Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
Figure 68. Cepheid Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
Figure 69. Hologic Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
Figure 70. Qiagen Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
Figure 71. Bio-Rad Laboratories Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
Figure 72. Siemens Healthcare Revenue Growth Rate in Infectious Diseases In Vitro Diagnostics Business (2019-2024)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Computer-Controlled Local Anesthetics Delivery Market Research Report 2025
May 20, 25
Global Barb and Cone Thread Market Research Report 2025
May 20, 25
Global MIYABI Angio-CT Market Research Report 2025
May 20, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232